ACNES
MCID: ANT066
MIFTS: 38

Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)

Categories: Neuronal diseases, Rare diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Anterior Cutaneous Nerve Entrapment Syndrome

MalaCards integrated aliases for Anterior Cutaneous Nerve Entrapment Syndrome:

Name: Anterior Cutaneous Nerve Entrapment Syndrome 58 75
Intercostal Nerve Syndrome 58
Rectus Abdominis Syndrome 58
Acnes 58

Characteristics:


Prevelance:

6-9/10000 (Netherlands) 58

Age Of Onset:

All ages 58

Classifications:

Orphanet: 58  
Rare neurological diseases


Summaries for Anterior Cutaneous Nerve Entrapment Syndrome

Orphanet: 58 A chronic neuropathic pain syndrome of the abdominal wall caused by entrapment of anterior cutaneous branches of 7 to 12th intercostal nerves along the lateral border of the anterior rectus abdominis fascia causing severe pain and tenderness of the involved dermatome.

MalaCards based summary: Anterior Cutaneous Nerve Entrapment Syndrome, also known as intercostal nerve syndrome, is related to acne and sarcoidosis 1. The drugs Benzoyl peroxide and Adapalene have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and bone marrow, and related phenotypes are abdominal pain and impaired tactile sensation

Wikipedia: 75 Anterior cutaneous nerve entrapment syndrome (ACNES) is a nerve entrapment condition that causes chronic... more...

Related Diseases for Anterior Cutaneous Nerve Entrapment Syndrome

Diseases related to Anterior Cutaneous Nerve Entrapment Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 314)
# Related Disease Score Top Affiliating Genes
1 acne 11.1
2 sarcoidosis 1 10.7
3 sarcoidosis 2 10.7
4 endophthalmitis 10.6
5 skin disease 10.6
6 endocarditis 10.6
7 dermatitis 10.5
8 osteomyelitis 10.5
9 infective endocarditis 10.4
10 uveitis 10.4
11 degenerative disc disease 10.3
12 anterior uveitis 10.3
13 intervertebral disc disease 10.3
14 paine syndrome 10.3
15 chronic pain 10.3
16 allergic disease 10.3
17 bone inflammation disease 10.3
18 pleural empyema 10.3
19 cataract 10.2
20 back pain 10.2
21 sapho syndrome 10.2
22 pericarditis 10.2
23 septic arthritis 10.2
24 cytokine deficiency 10.2
25 prosthetic joint infection 10.2
26 splenomegaly 10.2
27 functional neutrophil defect 10.2
28 intracranial abscess 10.2
29 discitis 10.2
30 rabies 10.2
31 synovitis 10.2
32 meningitis 10.2
33 cone-rod dystrophy 2 10.1
34 neuropathy, hereditary, with liability to pressure palsies 10.1
35 oculodentodigital dysplasia 10.1
36 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
37 gallbladder disease 1 10.1
38 mesenteric lymphadenitis 10.1
39 gastric ulcer 10.1
40 lymphadenitis 10.1
41 cholecystitis 10.1
42 gastritis 10.1
43 radiculopathy 10.1
44 nerve compression syndrome 10.1
45 appendicitis 10.1
46 crohn's disease 10.1
47 48,xyyy 10.1
48 lung cancer 10.1
49 kawasaki disease 10.1
50 bacteremia 2 10.1

Graphical network of the top 20 diseases related to Anterior Cutaneous Nerve Entrapment Syndrome:



Diseases related to Anterior Cutaneous Nerve Entrapment Syndrome

Symptoms & Phenotypes for Anterior Cutaneous Nerve Entrapment Syndrome

Human phenotypes related to Anterior Cutaneous Nerve Entrapment Syndrome:

58 30 (show all 17)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 abdominal pain 58 30 Hallmark (90%) Very frequent (99-80%)
HP:0002027
2 impaired tactile sensation 58 30 Hallmark (90%) Very frequent (99-80%)
HP:0010830
3 hyperhidrosis 58 30 Frequent (33%) Frequent (79-30%)
HP:0000975
4 vertigo 58 30 Frequent (33%) Frequent (79-30%)
HP:0002321
5 back pain 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0003418
6 anorexia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002039
7 hyperesthesia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0100963
8 abdominal distention 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0003270
9 elevated erythrocyte sedimentation rate 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0003565
10 leukocytosis 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0001974
11 nausea 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0002018
12 allodynia 58 30 Occasional (7.5%) Occasional (29-5%)
HP:0012533
13 inguinal hernia 58 30 Very rare (1%) Very rare (<4-1%)
HP:0000023
14 recurrent urinary tract infections 58 30 Very rare (1%) Very rare (<4-1%)
HP:0000010
15 decreased body weight 58 30 Very rare (1%) Very rare (<4-1%)
HP:0004325
16 recurrent infection of the gastrointestinal tract 58 30 Very rare (1%) Very rare (<4-1%)
HP:0004798
17 sensory impairment 58 Very frequent (99-80%)

Drugs & Therapeutics for Anterior Cutaneous Nerve Entrapment Syndrome

Drugs for Anterior Cutaneous Nerve Entrapment Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 47)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzoyl peroxide Approved Phase 4 94-36-0 7187
2
Adapalene Approved Phase 4 106685-40-9 60164
3
Ethanol Approved Phase 4 64-17-5 702
4
Chlorhexidine Approved, Vet_approved, Withdrawn Phase 4 55-56-1 2713 9552079
5
Sage Approved Phase 4
6 Dermatologic Agents Phase 4
7 Disinfectants Phase 4
8 Antirheumatic Agents Phase 4
9 Adapalene, Benzoyl Peroxide Drug Combination Phase 4
10 Anti-Inflammatory Agents, Non-Steroidal Phase 4
11 Anti-Inflammatory Agents Phase 4
12 Analgesics, Non-Narcotic Phase 4
13 Analgesics Phase 4
14 Anti-Infective Agents, Local Phase 4
15 Chlorhexidine gluconate Phase 4
16
Aminolevulinic acid Approved Phase 3 106-60-5 137
17 Photosensitizing Agents Phase 3
18
Minocycline Approved, Investigational Phase 2 10118-90-8, 13614-98-7 54675783 5281021
19
Clindamycin Approved, Vet_approved Phase 2 18323-44-9, 24729-96-2 29029
20 Omiganan pentahydrochloride Phase 2
21
Clindamycin phosphate Phase 2 32603
22 Clindamycin palmitate Phase 2
23
Iodine Approved, Investigational 7553-56-2 807
24
Ceftriaxone Approved 73384-59-5 5479530
25
Cefazolin Approved 25953-19-9 33255
26
Hydrogen peroxide Approved, Vet_approved 7722-84-1 784
27
Povidone-iodine Approved 25655-41-8
28
Doxycycline Approved, Investigational, Vet_approved 564-25-0 54671203
29
Azithromycin Approved 83905-01-5 447043
30
Zinc cation Approved, Experimental, Investigational 7440-66-6, 23713-49-7 32051
31
Cadexomer iodine Experimental 94820-09-4
32
Epigallocatechin gallate Investigational 989-51-5 65064
33
Epigallocatechin Experimental, Investigational 970-74-1 72277
34 Trace Elements
35 Micronutrients
36 Tea
37 Antiprotozoal Agents
38 Antiparasitic Agents
39 Antimalarials
40 Immunoglobulin A
41 Cephalosporins
42 beta-Lactams
43 Lactams
44 Pharmaceutical Solutions
45 Anti-Infective Agents
46 Antibiotics, Antitubercular
47 Anti-Bacterial Agents

Interventional clinical trials:

(show all 38)
# Name Status NCT ID Phase Drugs
1 Randomized Trial of Hibiclens vs Benzoyl Peroxide Soap for Surgical Preparation Completed NCT04021524 Phase 4 Benzoyl Peroxide 10% Bar;Chlorhexidine Gluconate
2 Evaluation of the Effectiveness of Epiduo® Gel (Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel) in Reducing Antibiotic Sensitive and Resistant Strains of P Acnes Completed NCT00907101 Phase 4 Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel (Epiduo® Gel)
3 Efficacy of Blue Light Therapy in Reducing Cutibacterium Acnes Bioburden at the Deltopectoral Interval Completed NCT04300010 Phase 4 5% Topical Benzoyl Peroxide Gel
4 Anti P. Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel in the Treatment of Subjects With Acne Vulgaris Completed NCT01188538 Phase 4 Epiduo gel;BPO
5 Effect of Antiseptic Irrigation With 0.05% Chlorhexidine Gluconate (Irrisept) on Incidence of Cutibacterium Acnes in Shoulder Arthroplasty Recruiting NCT03938467 Phase 4 Antiseptic Cleanser
6 Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis Unknown status NCT04636242 Phase 3 5 Aminolevulinic Acid + Phototherapy
7 Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients Recruiting NCT04028401 Phase 3 5% benzoyl peroxide
8 Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of MBI 226 2.5% and 5.0% Acne Solutions Applied Topically for 6 Weeks to Subjects With Acne Vulgaris Completed NCT00211523 Phase 2 MBI 226 Acne Solutions
9 A Phase II, Randomized, Vehicle-Controlled, Double-Blind, Multi-Center Study to Evaluate Safety and Efficacy of MBI 226 1.25% and 2.5% Acne Solutions Applied Topically for 12 Weeks to Subjects With Acne Vulgaris Completed NCT00211497 Phase 2 MBI 226 Acne Solutions
10 BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes Completed NCT02709096 Phase 2 BPX-01, 1% Topical Gel;BPX-01 Vehicle Gel
11 Cutibacterium Acnes Persists Despite Topical Clindamycin and Benzoyl Peroxide Completed NCT03257202 Phase 2 Clindamycin 1% Gel;Benzoyl peroxide 5% gel;BenzaClin 5%-1% Topical Gel
12 Can Additional Preoperative Skin Cleaning on Face, Neck and Chest With Chlorhexidine Reduce Cutibacterium Acnes Contamination on Sutures in Arthroscopy Rotator Cuff Repair? Unknown status NCT04483063 2% chlorhexidine gluconate skin cleanser
13 Cutibacterium Acnes in Bone and Joint Infections Unknown status NCT03950063
14 Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage Using Pore Strips in Humans Unknown status NCT03009903
15 Do Intra-incisional Subdermal Antibiotics Alter the Colony Count of P. Acnes Unknown status NCT03853096 Early Phase 1 Cefazolin
16 Does Preoperative Administration of Oral Doxycycline Decrease the Colonization Rate of Propionibacterium Acnes in the Dermis of the Shoulder? Unknown status NCT02688738 Doxycycline
17 Does the Disinfection of the Subcutaneous Tissue Reduce the Contamination of the Operative Field by P. Acnes During Primary Shoulder Surgery? Unknown status NCT03664284
18 Does the Addition of Hydrogen Peroxide to Chlorhexidine Preoperative Skin Preparation Reduce the Rate of Propionibacterium Acnes Positive Culture in the Shoulder Unknown status NCT03656588 a. Standard iodine scrub, 3% hydrogen peroxide prep, follow by ChloraPrep (2% chlorhexidine gluconate and 70% isopropyl alcohol;Iodine scrub and ChloraPrep alone
19 Nociceptive Processing in Acute Cutaneous Nerve Entrapment Syndrome: a Quantitative Sensory Testing Analysis. Completed NCT01920880
20 Does Hydrogen Peroxide Skin Preparation Reduce Propionibacterium Acnes in Shoulder Arthroplasty? Completed NCT03057821
21 Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris Completed NCT01929057
22 Chronic Infections on Articular Prostheses With C. Acnes Diagnosed by Specific PCR : Descriptive Study of 6 Patients Completed NCT03850548
23 Epigallocatechin-3-Gallate Improves Acne in Humans by Modulating Intracellular Molecular Targets and Inhibiting P. Acnes Completed NCT01687556
24 Can Addition of Doxycycline Perioperatively Reduce Propionibacterium Acnes in Shoulder Arthroplasty? Completed NCT03115177 Doxycycline;Cefazolin
25 Characterization of Immune Responses Against Acne-associated Bacterium Propionibacterium Acnes - a Pilot Study Completed NCT04056598
26 Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID): a Prospective Cohort Completed NCT03158766
27 Adjusting Skin Prep to Decrease Risk of P. Acnes Related Shoulder Infection Completed NCT02510144 Skin Prep Chlorhexidine;Skin Prep Benzoyl Peroxide
28 Can Propionibacterium Acnes Load in Primary Shoulder Surgery be Reduced With Preoperative Application of a Benzoylperoxid/Miconazolnitrat crème Additional to Standard Antibiotic Prophylaxis Completed NCT03949751 Acne Crème Plus
29 Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery: A Double Blinded Randomized Controlled Trial Recruiting NCT02996656 Cefazolin;Ceftriaxone
30 Efficacy of Surgical Diathermy in Eradicating Cutibacterium Acnes From Surgical Skin Incision During Shoulder Arthroplasty Recruiting NCT04608916
31 The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty; a Pilot Study Recruiting NCT04112407 Benzyl Peroxide
32 Cutibacterium Acnes Colonization on Intervertebral Discs of Patients With Low Back Pain: Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques Recruiting NCT05090553
33 How Does Hydrogen Peroxide Application to the Wound Following Surgical Incision Affect C. Acnes Cultures in Primary Shoulder Arthroplasty? Active, not recruiting NCT04609306
34 Visualizing Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) and Lumbar Cutaneous Nerve Entrapment Syndrome (LUCNES) With Dynamic Infrared Thermography (DIRT) Not yet recruiting NCT05080452
35 Does Disinfection of the Subcutaneous Tissue Reduce Contamination of the Operating Field With P. Acnes Compared to Dissection With an Electric Cautery During Primary Shoulder Surgery Not yet recruiting NCT04250649
36 PHENOtype Based Therapy With Antibiotics in SARcoidosis Patients With and Without Presence of Cutibacterium Acnes in Granulomatous Tissue Not yet recruiting NCT05291468
37 Can Benzoyl Peroxide Decrease the Burden of Cutibacterium Acnes in Primary Spine and Shoulder Surgery? Prospective Randomized Study Not yet recruiting NCT05355844 Benzoyl peroxide
38 Preoperative Application of Low-level Microcurrent Dressing (Jumpstart) for Decolonization of P. Acnes Before Shoulder Surgery Terminated NCT03466658

Search NIH Clinical Center for Anterior Cutaneous Nerve Entrapment Syndrome

Genetic Tests for Anterior Cutaneous Nerve Entrapment Syndrome

Anatomical Context for Anterior Cutaneous Nerve Entrapment Syndrome

Organs/tissues related to Anterior Cutaneous Nerve Entrapment Syndrome:

MalaCards : Skin, Bone, Bone Marrow, Prostate, Liver, Whole Blood, Myeloid

Publications for Anterior Cutaneous Nerve Entrapment Syndrome

Articles related to Anterior Cutaneous Nerve Entrapment Syndrome:

(show top 50) (show all 4450)
# Title Authors PMID Year
1
Thymus mastichina (L.) L. and Cistus ladanifer L. for skin application: chemical characterization and in vitro bioactivity assessment. 62
36243295 2023
2
Bacteriophages: An Alternative to Combat Antibiotic Resistance? 62
36468950 2022
3
Red Light-Mediated Photoredox Catalysis Triggers Nitric Oxide Release for Treatment of Cutibacterium Acne Induced Intervertebral Disc Degeneration. 62
36469724 2022
4
The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacteriumacnes. 62
34950868 2022
5
Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. 62
36473894 2022
6
The increasing importance of the gut microbiome in acne vulgaris. 62
35711021 2022
7
D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against Cutibacterium acnes. 62
35266431 2022
8
Preparation and optimization of aloe ferox gel loaded with Finasteride-Oregano oil nanocubosomes for treatment of alopecia. 62
35019794 2022
9
Extended skin cleaning on the shoulder with chlorhexidine reduces the cutaneous bacterial load but fails to decrease suture contamination in patients undergoing arthroscopy rotator cuff repair. 62
36464206 2022
10
18 F-NaF PET/CT in Presumed Aseptic Pseudarthrosis after Spinal Fusion: Correlation with Findings at Revision Surgery and Intraoperative Cultures. 62
36398308 2022
11
Changes of the microbiological spectrum and antibiotic resistance pattern in postoperative spinal implant infections with multiple culture-positive revision surgeries. 62
35853535 2022
12
Arthroscopic revision cuff repair: do tendons have a second chance to heal? 62
35671929 2022
13
Alpha-Defensin Offers Limited Utility in Work-Up Prior to Reimplantation in Chronic Periprosthetic Joint Infection in Total Joint Arthroplasty Patients. 62
35803520 2022
14
Many Common Pathogens are Present in the Operative Room Air During Surgery. 62
35843378 2022
15
Positive Cultures Can Be Safely Ignored in Revision Arthroplasty Patients That Do Not Meet the 2018 International Consensus Meeting Criteria. 62
35569707 2022
16
Rapid detection of bacteria using gold nanoparticles in SERS with three different capping agents: Thioglucose, polyvinylpyrrolidone, and citrate. 62
35752039 2022
17
Prospective evaluation of the prevalence of conjunctival and intraocular bacteria in dogs undergoing phacoemulsification following a standardized aseptic preparation with 0.5% povidone iodine. 62
36083221 2022
18
Green synthesis of guar gum/Ag nanoparticles and their role in peel-off gel for enhanced antibacterial efficiency and optimization using RSM. 62
36089092 2022
19
Ultrasound evaluations and guided procedures of the painful joint arthroplasty. 62
35624311 2022
20
Propolis Efficacy: The Quest for Eco-Friendly Solvents. 62
36364353 2022
21
Metagenomic characterization of bacterial community and antibiotic resistance genes found in the mass transit system in Seoul, South Korea. 62
36257123 2022
22
Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth Times. 62
36377888 2022
23
The Choice of Antibiotic Prophylaxis Influences the Infection Reoperation Rate in Primary Shoulder Arthroplasty: Analysis From the Swedish Shoulder Arthroplasty Register. 62
36410009 2022
24
What is the Optimal Management of a Loose Glenoid Component after Anatomic Total Shoulder Arthroplasty: A Systematic Review. 62
36343791 2022
25
CUTIS-SEQ, a flexible bilocus sequence typing scheme that provides high resolution of Cutibacterium acnes strains across all subspecies. 62
36455756 2022
26
What is the concordance rate of preoperative synovial fluid aspiration and intraoperative biopsy in detecting periprosthetic joint infection of the shoulder ? 62
36343792 2022
27
Unexpected intraoperative positive culture (UIPC) in presumed aseptic revision spine surgery: A systematic review and meta-analysis. 62
36336255 2022
28
Temporal Trends in Deep Surgical Site Infections After Six Orthopaedic Procedures Over a 12-year Period Within a US-based Healthcare System. 62
36084332 2022
29
Revision surgery after failed surgical treatment of midshaft clavicle fractures is often associated with positive detection of bacteria. 62
36383227 2022
30
Correction to: Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling. 62
36087162 2022
31
Low Curcumin Concentrations Combined with Blue Light Inhibits Cutibacterium Acnes Biofilm-induced Inflammatory Response through Suppressing MAPK and NF-κB in Keratinocytes. 62
36403927 2022
32
New cyclic diarylheptanoids from the false heartwood of Betula pubescens Ehrh. 62
34935543 2022
33
Transvaginal Mesh-Related Complications and the Potential Role of Bacterial Colonization: an Exploratory Observational Study. 62
36442754 2022
34
Extracellular electrons transferred from honey probiotic Bacillus circulans inhibits inflammatory acne vulgaris. 62
36357775 2022
35
High-frequency devices effect in vitro: promissing approach in the treatment of acne vulgaris? 62
36109271 2022
36
Prevalence of antimicrobial-resistant Cutibacterium isolates and development of multiplex PCR method for Cutibacterium species identification. 62
36336238 2022
37
Topical methylene blue nanoformulation for the photodynamic therapy of acne vulgaris. 62
36376760 2022
38
Characterization of a live Cutibacterium acnes subspecies defendens strain XYCM42 and clinical assessment as a topical regimen for general skin health and cosmesis. 62
36374551 2022
39
Microbiological composition of follicular fluid in patients undergoing IVF and its association with infertility. 62
36397134 2022
40
Sulforaphene Attenuates Cutibacterium acnes-Induced Inflammation. 62
36437519 2022
41
The hero of American and Polish nations: a molecular look at Thaddeus Kosciuszko's cause of death suggests a contribution of endocarditis caused by Cutibacterium acnes infection. 62
36419091 2022
42
Carbon Peeling Laser Treatment to Improve Skin Texture, Pores and Acne Lesions: A Retrospective Study. 62
36422207 2022
43
A randomized comparative double-blind study assessing the difference between topically applied microbiome supporting skincare versus conventional skincare on the facial microbiome in correlation to biophysical skin parameters. 62
36367009 2022
44
[Better Late than Never - Fever of Unknown Origin in a Patient with a Prosthetic Valve]. 62
36415980 2022
45
[Cutibacterium acnes Artificial Valve Endocarditis: A Difficult Diagnosis]. 62
36415985 2022
46
Garcinia mangostana hydrogel patch: bactericidal activity and clinical safety for acne vulgaris treatment. 62
36386483 2022
47
Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma. 62
35390349 2022
48
Management of Holospinal Epidural Abscess. 62
35863647 2022
49
Distinct skin microbiome community structures in congenital ichthyosis. 62
35633118 2022
50
Detection of Cutibacterium acnes from multiple miliary osteoma cutis. 62
36285033 2022

Variations for Anterior Cutaneous Nerve Entrapment Syndrome

Expression for Anterior Cutaneous Nerve Entrapment Syndrome

Search GEO for disease gene expression data for Anterior Cutaneous Nerve Entrapment Syndrome.

Pathways for Anterior Cutaneous Nerve Entrapment Syndrome

GO Terms for Anterior Cutaneous Nerve Entrapment Syndrome

Sources for Anterior Cutaneous Nerve Entrapment Syndrome

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....